Advanced search
Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 28, 2006 - Issue 6: Impact of Heart Disease and Stroke on Alzheimer’s Disease
Submit an article Journal homepage
694
Views
202
CrossRef citations to date
0
Altmetric
Articles

Update on hypertension and Alzheimer's disease

Ingmar SkoogInstitute of Neuroscience and PhysiologySection of Psychiatry, Unite of Neuropsychiatric Epidemiology, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden
&
Deborah GustafsonInstitute of Neuroscience and PhysiologySection of Psychiatry, Unite of Neuropsychiatric Epidemiology, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden
Pages 605-611 | Published online: 19 Jul 2013

Citations (202)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Noushin Yazdani, Mark S. Kindy & Saeid Taheri. (2020) CBF regulation in hypertension and Alzheimer’s disease. Clinical and Experimental Hypertension 42:7, pages 622-639.
Read now
B Ng Justin, Michele Turek & Antoine M Hakim. (2013) Heart disease as a risk factor for dementia. Clinical Epidemiology 5, pages 135-145.
Read now
Gjumrakch Aliev, Eldar Gasimov, Mark E Obrenovich, Kathryn Fischbach, Justin C Shenk, Mark A Smith & George Perry. (2008) Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: Implication in the pathogenesis of Alzheimer’s disease. Vascular Health and Risk Management 4:3, pages 721-730.
Read now
Sergio L. Blay, Ariane Furtado & Érica T.P. Peluso. (2008) Knowledge and beliefs about help-seeking behavior and helpfulness of interventions for Alzheimer's disease. Aging & Mental Health 12:5, pages 577-586.
Read now
Kevin R Scott & Anna M Barrett. (2007) Dementia syndromes: evaluation and treatment. Expert Review of Neurotherapeutics 7:4, pages 407-422.
Read now
C. A. Szekely, J. C. S. Breitner & P. P. Zandi. (2007) Prevention of Alzheimer's disease. International Review of Psychiatry 19:6, pages 693-706.
Read now

Articles from other publishers (196)

Md Sharyful Islam, Chih-Chia Lai, Lan-Hui Wang & Hsun-Hsun Lin. (2023) Inhibition of NMDA Receptor Activation in the Rostral Ventrolateral Medulla by Amyloid-β Peptide in Rats. Biomolecules 13:12, pages 1736.
Crossref
Yousef Hannawi. (2023) Cerebral Small Vessel Disease: a Review of the Pathophysiological Mechanisms. Translational Stroke Research.
Crossref
Donné Minné, Juliet Stromin, Taskeen Docrat, Penelope Engel-Hills & Jeanine L. Marnewick. (2023) The effects of tea polyphenols on emotional homeostasis: Understanding dementia risk through stress, mood, attention & sleep. Clinical Nutrition ESPEN 57, pages 77-88.
Crossref
Tamas Pandics, David Major, Vince Fazekas-Pongor, Zsofia Szarvas, Anna Peterfi, Peter Mukli, Rafal Gulej, Anna Ungvari, Monika Fekete, Anna Tompa, Stefano Tarantini, Andriy Yabluchanskiy, Shannon Conley, Anna Csiszar, Adam G. Tabak, Zoltan Benyo, Roza Adany & Zoltan Ungvari. (2023) Exposome and unhealthy aging: environmental drivers from air pollution to occupational exposures. GeroScience 45:6, pages 3381-3408.
Crossref
Abdelkader Basli & Jihane Bounaas. (2022) Pathophysiological mechanism and natural preventive and therapeutic strategies of Alzheimer's disease. Nutrition and Health 29:3, pages 403-413.
Crossref
John P. LaporteMary E. FaulknerZhaoyuan Gong, Mohammad A.B.S. AkhondaLuigi Ferrucci, Josephine M. EganMustapha Bouhrara. (2023) Hypertensive Adults Exhibit Lower Myelin Content: A Multicomponent Relaxometry and Diffusion Magnetic Resonance Imaging Study. Hypertension 80:8, pages 1728-1738.
Crossref
Yashumati Ratan, Aishwarya Rajput, Sushmita Maleysm, Aaushi Pareek, Vivek Jain, Ashutosh Pareek, Ranjeet Kaur & Gurjit Singh. (2023) An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer’s Disease. Biomedicines 11:5, pages 1398.
Crossref
Donné Minné, Jeanine L. Marnewick & Penelope Engel-Hills. (2023) Early Chronic Stress Induced Changes within the Locus Coeruleus in Sporadic Alzheimer’s Disease. Current Alzheimer Research 20:5, pages 301-317.
Crossref
Amaia Ezkurdia, María J. Ramírez & Maite Solas. (2023) Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance. International Journal of Molecular Sciences 24:5, pages 4354.
Crossref
Olalla Sáiz-Vazquez, Alicia Puente-Martínez, Joaquín Pacheco-Bonrostro & Silvia Ubillos-Landa. (2023) Blood pressure and Alzheimer's disease: A review of meta-analysis. Frontiers in Neurology 13.
Crossref
Maya Pandit & William H. Frishman. (2023) The Association Between Cardiovascular Disease and Dementia: A Review of Trends in Epidemiology, Risk Factors, Pathophysiologic Mechanisms, and Clinical Implications. Cardiology in Review Publish Ahead of Print.
Crossref
Joseph E. Malone, Mohamed I. Elkasaby & Alan J. Lerner. (2022) Effects of Hypertension on Alzheimer’s Disease and Related Disorders. Current Hypertension Reports 24:12, pages 615-625.
Crossref
Mahesh S. Joshi & James E. Galvin. (2022) Cognitive Resilience in Brain Health and Dementia Research. Journal of Alzheimer's Disease 90:2, pages 461-473.
Crossref
Song Hwangbo, Young Ju Kim, Yu Hyun Park, Hee Jin Kim, Duk L. Na, Hyemin Jang & Sang Won Seo. (2022) Relationships between educational attainment, hypertension, and amyloid negative subcortical vascular dementia: The brain-battering hypothesis. Frontiers in Neuroscience 16.
Crossref
Abhishek Singh, Parul Gupta, Shubhangini Tiwari, Amit Mishra & Sarika Singh. (2022) Guanabenz mitigates the neuropathological alterations and cell death in Alzheimer’s disease. Cell and Tissue Research 388:2, pages 239-258.
Crossref
Todd E. Golde. (2022) Alzheimer’s disease – the journey of a healthy brain into organ failure. Molecular Neurodegeneration 17:1.
Crossref
Helene Benveniste & Maiken Nedergaard. (2022) Cerebral small vessel disease: A glymphopathy?. Current Opinion in Neurobiology 72, pages 15-21.
Crossref
Yijing Tang, Dong Zhang, Xiong Gong & Jie Zheng. (2022) A mechanistic survey of Alzheimer's disease. Biophysical Chemistry 281, pages 106735.
Crossref
Atef Badji, Joana B. Pereira, Sara Shams, Johan Skoog, Anna Marseglia, Konstantinos Poulakis, Lina Rydén, Kaj Blennow, Henrik Zetterberg, Silke Kern, Anna Zettergren, Lars-Olof Wahlund, Hélène Girouard, Ingmar Skoog & Eric Westman. (2022) Cerebrospinal Fluid Biomarkers, Brain Structural and Cognitive Performances Between Normotensive and Hypertensive Controlled, Uncontrolled and Untreated 70-Year-Old Adults. Frontiers in Aging Neuroscience 13.
Crossref
Patrick G Kehoe, Nicholas Turner, Beth Howden, Lina Jarutyt, Shona L Clegg, Ian B Malone, Josephine Barnes, Casper Nielsen, Carole H Sudre, Aileen Wilson, N Jade Thai, Peter S Blair, Elizabeth J Coulthard, J Athene Lane, Peter Passmore, Jodi Taylor, Henk-Jan Mutsaerts, David L Thomas, Nick C Fox, Ian Wilkinson & Yoav Ben-Shlomo. (2021) Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT. Efficacy and Mechanism Evaluation 8:19, pages 1-72.
Crossref
Elizabeth Disbrow, Karen Y. Stokes, Christina Ledbetter, James Patterson, Roger Kelley, Sibile Pardue, Tyler Reekes, Lana Larmeu, Vinita Batra, Shuai Yuan, Urska Cvek, Marjan Trutschl, Phillip Kilgore, J. Steven Alexander & Christopher G. Kevil. (2021) Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementias. Alzheimer's & Dementia 17:8, pages 1391-1402.
Crossref
Gloria Hoi-Yee Li, Ching-Lung Cheung, Elaine Yun-Ning Cheung, Wai-Chi Chan & Kathryn Choon-Beng Tan. (2021) Genetically Determined TSH Level Within Reference Range Is Inversely Associated With Alzheimer Disease. The Journal of Clinical Endocrinology & Metabolism.
Crossref
Meilin She, Suhang Shang, Ningwei Hu, Chen Chen, Liangjun Dang, Ling Gao, Shan Wei, Kang Huo, Jingyi Wang, Jin Wang & Qiumin Qu. (2021) Blood Pressure Level Is Associated With Changes in Plasma Aβ1 –40 and Aβ1–42 Levels: A Cross-sectional Study Conducted in the Suburbs of Xi’an, China. Frontiers in Aging Neuroscience 13.
Crossref
Sanny Scheffer, Dorien M.A. Hermkens, Louise van der WeerdHelga E. de VriesMat J.A.P. Daemen. (2021) Vascular Hypothesis of Alzheimer Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 41:4, pages 1265-1283.
Crossref
Molly Fox, Prabha Siddarth, Hanadi Ajam Oughli, Sarah A Nguyen, Michaela M Milillo, Yesenia Aguilar, Linda Ercoli & Helen Lavretsky. (2021) Women who breastfeed exhibit cognitive benefits after age 50. Evolution, Medicine, and Public Health 9:1, pages 322-331.
Crossref
Pragya Prasanna & Arun Upadhyay. (2021) Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go. ACS Pharmacology & Translational Science 4:1, pages 74-95.
Crossref
Aida Muntsant, Francesc Jiménez-Altayó, Lidia Puertas-Umbert, Elena Jiménez-Xarrie, Elisabet Vila & Lydia Giménez-Llort. (2021) Sex-Dependent End-of-Life Mental and Vascular Scenarios for Compensatory Mechanisms in Mice with Normal and AD-Neurodegenerative Aging. Biomedicines 9:2, pages 111.
Crossref
Minghao Yuan, Yangyang Wang, Shengyuan Wang, Zhenting Huang, Feng Jin, Qian Zou, Jing Li, Yinshuang Pu & Zhiyou Cai. (2021) Bioenergetic Impairment in the Neuro-Glia-Vascular Unit: An Emerging Physiopathology during Aging. Aging and disease 12:8, pages 2080.
Crossref
Akhlaq A. Farooqui. 2021. Molecular Aspects of Neurodegeneration, Neuroprotection, and Regeneration in Neurological Disorders. Molecular Aspects of Neurodegeneration, Neuroprotection, and Regeneration in Neurological Disorders 117 148 .
Devin Loewenstein & Mark Rabbat. 2021. Heart and Neurologic Disease. Heart and Neurologic Disease 253 259 .
Jerzy Leszek, Elizaveta V. Mikhaylenko, Dmitrii M. Belousov, Efrosini Koutsouraki, Katarzyna Szczechowiak, Małgorzata Kobusiak-Prokopowicz, Andrzej Mysiak, Breno Satler Diniz, Siva G. Somasundaram, Cecil E. Kirkland & Gjumrakch Aliev. (2020) The Links between Cardiovascular Diseases and Alzheimer's Disease. Current Neuropharmacology 19:2, pages 152-169.
Crossref
Isabelle Pelcher, Christian Puzo, Yorghos Tripodis, Hugo J. Aparicio, Eric G. Steinberg, Alyssa Phelps, Brett Martin, Joseph N. Palmisano, Elizabeth Vassey, Cutter Lindbergh, Ann C. McKee, Thor D. Stein, Ronald J. Killiany, Rhoda Au, Neil W. Kowall, Robert A. Stern, Jesse Mez & Michael L. Alosco. (2020) Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures. Journal of Alzheimer's Disease 78:4, pages 1393-1408.
Crossref
Amalia C. Bruni, Livia Bernardi & Carlo Gabelli. (2020) From beta amyloid to altered proteostasis in Alzheimer’s disease. Ageing Research Reviews 64, pages 101126.
Crossref
David F. Wilson & Franz M. Matschinsky. (2020) Cerebrovascular Blood Flow Design and Regulation; Vulnerability in Aging Brain. Frontiers in Physiology 11.
Crossref
Cristina Barbagallo, Maria Teresa Di Martino, Margherita Grasso, Maria Grazia Salluzzo, Francesca Scionti, Filomena Irene Ilaria Cosentino, Giuseppe Caruso, Davide Barbagallo, Cinzia Di Pietro, Raffaele Ferri, Filippo Caraci, Michele Purrello & Marco Ragusa. (2020) Uncharacterized RNAs in Plasma of Alzheimer’s Patients Are Associated with Cognitive Impairment and Show a Potential Diagnostic Power. International Journal of Molecular Sciences 21:20, pages 7644.
Crossref
Jessika Royea & Edith Hamel. (2020) Brain angiotensin II and angiotensin IV receptors as potential Alzheimer’s disease therapeutic targets. GeroScience 42:5, pages 1237-1256.
Crossref
Leah K. Cuddy, Dmitry Prokopenko, Eric P. Cunningham, Ross BrimberryPeter Song, Rory Kirchner, Brad A. ChapmanOliver Hofmann, Winston Hide, Daniele Procissi, Taleen Hanania, Steven C. LeiserRudolph E Tanzi & Robert Vassar. (2020) Aβ-accelerated neurodegeneration caused by Alzheimer’s-associated ACE variant R1279Q is rescued by angiotensin system inhibition in mice . Science Translational Medicine 12:563.
Crossref
Eva Ausó, Violeta Gómez-Vicente & Gema Esquiva. (2020) Biomarkers for Alzheimer’s Disease Early Diagnosis. Journal of Personalized Medicine 10:3, pages 114.
Crossref
Ernesto Solis,, Kevin N. Hascup & Erin R. Hascup. (2020) Alzheimer’s Disease: The Link Between Amyloid-β and Neurovascular Dysfunction. Journal of Alzheimer's Disease 76:4, pages 1179-1198.
Crossref
Joanna Kapusta, Tit Michał Kidawa, Monika Rynkowska‐Kidawa, Tit Robert IrzmaŃski & Tit Jan Kowalski. (2020) Evaluation of frequency of occurrence of cognitive impairment in the course of arterial hypertension in an elderly population. Psychogeriatrics 20:4, pages 406-411.
Crossref
Dmitry Prokopenko, Julian Hecker, Rory Kirchner, Brad A. Chapman, Oliver Hoffman, Kristina Mullin, Winston Hide, Lars Bertram, Nan Laird, Dawn L. DeMeo, Christoph Lange & Rudolph E. Tanzi. (2020) Identification of Novel Alzheimer’s Disease Loci Using Sex-Specific Family-Based Association Analysis of Whole-Genome Sequence Data. Scientific Reports 10:1.
Crossref
Grażyna Söderbom & Bai-Yun Zeng. 2020. Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Neurodegenerative Disease Research and Commonalities with Metabolic Diseases. Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Neurodegenerative Disease Research and Commonalities with Metabolic Diseases 345 391 .
Marcos Vinícius Ferreira Silva, Cristina de Mello Gomide Loures, Luan Carlos Vieira Alves, Leonardo Cruz de Souza, Karina Braga Gomes Borges & Maria das Graças Carvalho. (2019) Alzheimer’s disease: risk factors and potentially protective measures. Journal of Biomedical Science 26:1.
Crossref
Wei Jin, Talal Jamil Qazi, Zhenzhen Quan, Nuomin Li & Hong Qing. (2018) Dysregulation of Transcription Factors: A Key Culprit Behind Neurodegenerative Disorders. The Neuroscientist 25:6, pages 548-565.
Crossref
Gordon J. Smilnak, John R. Deans, P. Murali Doraiswamy, Sandra Stinnett, Heather E. Whitson & Eleonora M. Lad. (2019) Comorbidity of age-related macular degeneration with Alzheimer’s disease: A histopathologic case-control study. PLOS ONE 14:9, pages e0223199.
Crossref
Molly Fox, Delaney A. Knorr & Kacey M. Haptonstall. (2019) Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective. Annals of the New York Academy of Sciences 1449:1, pages 3-24.
Crossref
Miguel Germán Borda, José Manuel Santacruz, Dag Aarsland, Sandy Camargo-Casas, Carlos Alberto Cano-Gutierrez, Silvia Suárez-Monsalve, Santiago Campos-Fajardo & Mario Ulises Pérez-Zepeda. (2019) Association of depressive symptoms and subjective memory complaints with the incidence of cognitive impairment in older adults with high blood pressure. European Geriatric Medicine 10:3, pages 413-420.
Crossref
Arnaldina Sampaio, Elisa A Marques, Jorge Mota & Joana Carvalho. (2016) Effects of a multicomponent exercise program in institutionalized elders with Alzheimer’s disease. Dementia 18:2, pages 417-431.
Crossref
Shari R. Waldstein, S. Carrington Rice Wendell, Megan M. Hosey, Stephen L. Seliger & Leslie I. Katzel. 2019. Handbook of Medical Neuropsychology. Handbook of Medical Neuropsychology 99 134 .
Cristina Carvalho & Paula I. Moreira. (2018) Oxidative Stress: A Major Player in Cerebrovascular Alterations Associated to Neurodegenerative Events. Frontiers in Physiology 9.
Crossref
Daniela P. Stocher, Caroline P. Klein, André B. Saccomori, Pauline M. August, Nicolli C. Martins, Pablo R. G. Couto, Martine E. K. Hagen & Cristiane Matté. (2018) Maternal high-salt diet alters redox state and mitochondrial function in newborn rat offspring’s brain. British Journal of Nutrition 119:9, pages 1003-1011.
Crossref
Francesca Pistollato, Ruben Calderón Iglesias, Roberto Ruiz, Silvia Aparicio, Jorge Crespo, Luis Dzul Lopez, Piera Pia Manna, Francesca Giampieri & Maurizio Battino. (2018) Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer’s disease: A focus on human studies. Pharmacological Research 131, pages 32-43.
Crossref
Patrick Gavin Kehoe. (2018) The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?. Journal of Alzheimer's Disease 62:3, pages 1443-1466.
Crossref
Elena V. Kugaevskaya, Alexander V. Veselovsky, Maria I. Indeykina, Nina I. Solovyeva, Maria S. Zharkova, Igor A. Popov, Eugene N. Nikolaev, Alexey B. Mantsyzov, Alexander A. Makarov & Sergey A. Kozin. (2018) N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer’s disease. Scientific Reports 8:1.
Crossref
Patrick G. Kehoe, Peter S. Blair, Beth Howden, David L. Thomas, Ian B. Malone, Jeremy Horwood, Clare Clement, Lucy E. Selman, Hannah Baber, Athene Lane, Elizabeth Coulthard, Anthony Peter Passmore, Nick C. Fox, Ian B. Wilkinson & Yoav Ben-Shlomo. (2017) The Rationale and Design of the Reducing Pathology in Alzheimer’s Disease through Angiotensin TaRgeting (RADAR) Trial. Journal of Alzheimer's Disease 61:2, pages 803-814.
Crossref
Jean K. Ho & Daniel A. Nation. (2017) Memory is preserved in older adults taking AT1 receptor blockers. Alzheimer's Research & Therapy 9:1.
Crossref
Jong-Chan Park, Sun-Ho Han, Hyun Jin Cho, Min Soo Byun, Dahyun Yi, Young Min Choe, Seokjo Kang, Eun Sun Jung, Su Jin Won, Eun Hye Kim, Yu Kyeong Kim, Dong Young Lee & Inhee Mook-Jung. (2017) Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition. Alzheimer's Research & Therapy 9:1.
Crossref
Hugo Geerts, Athan Spiros, Patrick Roberts & Robert Carr. (2017) Towards the virtual human patient. Quantitative Systems Pharmacology in Alzheimer's disease. European Journal of Pharmacology 817, pages 38-45.
Crossref
Tobias Haeusermann. (2017) The dementias – A review and a call for a disaggregated approach. Journal of Aging Studies 42, pages 22-31.
Crossref
Anna Csiszar, Stefano Tarantini, Gábor A. Fülöp, Tamas Kiss, M. Noa Valcarcel-Ares, Veronica Galvan, Zoltan Ungvari & Andriy Yabluchanskiy. (2017) Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer’s disease. GeroScience 39:4, pages 359-372.
Crossref
Ingrid Prkačin, Helena Zorko & Vesna Herceg-Čavrak. (2017) Association of mental health, obesity and arterial hypertension. Cardiologia Croatica 12:7-8, pages 325-329.
Crossref
Keith A. Hawkins, Nazli Emadi, Godfrey D. Pearlson, Anderson M. Winkler, Beth Taylor, Latha Dulipsingh, Diana King, Brian Pittman & Karen Blank. (2017) Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients. Metabolic Brain Disease 32:3, pages 849-857.
Crossref
Yu-Lang Fei, Hong-Jun Lv, Yan-Bo Li, Jie Liu, Yi-Hua Qian, Wei-Na Yang, Kai-Ge Ma, Hong-Bao Li & Qiu-Min Qu. (2017) Tongxinluo improves cognition by decreasing β-amyloid in spontaneous hypertensive rats. Brain Research 1663, pages 151-160.
Crossref
Mak Adam Daulatzai. (2017) Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease. Journal of Neuroscience Research 95:4, pages 943-972.
Crossref
. (2017) Cardiovascular Alterations in Patients with Dementia. Journal of Cardiology & Current Research 8:1.
Crossref
Peter Toth, Stefano TarantiniAnna Csiszar & Zoltan Ungvari. (2017) Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. American Journal of Physiology-Heart and Circulatory Physiology 312:1, pages H1-H20.
Crossref
Cláudia Y. Santos, Peter J. Snyder, Wen‐Chih Wu, Mia Zhang, Ana Echeverria & Jessica Alber. (2017) Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 7:1, pages 69-87.
Crossref
A. Hadar, I. Gozes & D. Gurwitz. 2017. Neuroprotection in Alzheimer's Disease. Neuroprotection in Alzheimer's Disease 239 251 .
I. Sebastião, E. Candeias, M. S. Santos, C. R. Oliveira, Paula I. Moreira & Ana I. Duarte. 2017. Neuroprotective Therapy for Stroke and Ischemic Disease. Neuroprotective Therapy for Stroke and Ischemic Disease 711 731 .
Jennifer Kirsty Harrison, Veronika Van Der Wardt, Simon Paul Conroy, David J. Stott, Tom Dening, Adam Lee Gordon, Pip Logan, Tomas James Welsh, Jaspal Taggar, Rowan Harwood & John R. F. Gladman. (2016) New horizons: the management of hypertension in people with dementia. Age and Ageing 45:6, pages 740-746.
Crossref
R Archana, Kumar Sai Sailesh, Jobby Abraham, Soumya Mishra, Udaya Kumar Reddy & J K Mukkadan. (2016) Prevention/delay of Alzheimer’s Disease by Vestibular Stimulation: A Hypothesis. Journal of Medical Sciences and Health 02:03, pages 30-33.
Crossref
Saeid Taheri, Jin Yu, Hong Zhu & Mark S. Kindy. (2016) High-Sodium Diet Has Opposing Effects on Mean Arterial Blood Pressure and Cerebral Perfusion in a Transgenic Mouse Model of Alzheimer’s Disease. Journal of Alzheimer's Disease 54:3, pages 1061-1072.
Crossref
Andrew M. Roberts, Rekha Jagadapillai, Radhika A. Vaishnav, Robert P. Friedland, Robert Drinovac, Xingyu Lin & Evelyne Gozal. (2016) Increased pulmonary arteriolar tone associated with lung oxidative stress and nitric oxide in a mouse model of Alzheimer's disease. Physiological Reports 4:17, pages e12953.
Crossref
Xin Li, Chao Ma, Xuan Sun, Junying Zhang, Yaojing Chen, Kewei Chen & Zhanjun Zhang. (2015) Disrupted white matter structure underlies cognitive deficit in hypertensive patients. European Radiology 26:9, pages 2899-2907.
Crossref
Achille E. Tchalla, Gregory A. Wellenius, Farzaneh A. Sorond, Margaret Gagnon, Ikechukwu Iloputaife, Thomas G. Travison, Thierry Dantoine & Lewis A. Lipsitz. (2016) Elevated Soluble Vascular Cell Adhesion Molecule-1 Is Associated With Cerebrovascular Resistance and Cognitive Function. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, pages glw099.
Crossref
Sunmin Jung, Jihoon Nah, Jonghee Han, Seon-Guk Choi, Hyunjoo Kim, Jaesang Park, Ha-Kyung Pyo & Yong-Keun Jung. (2016) Dual-specificity phosphatase 26 (DUSP26) stimulates Aβ42 generation by promoting amyloid precursor protein axonal transport during hypoxia. Journal of Neurochemistry 137:5, pages 770-781.
Crossref
Meral Demir, Ali Osman Gürol, Raşit Tolga Özyiğit & Ali Yağz Üresin. (2016) Effects of Blood Pressure Lowering With Different Antihypertensive Agents on Cognitive Function and Plasma Brain-derived Neurotrophic Factor Levels. Journal of Cardiovascular Pharmacology 67:6, pages 538-543.
Crossref
Jason E. Kisser, Allyssa J. Allen, Leslie I. Katzel, Carrington R. Wendell, Eliot L. Siegel, David Lefkowitz & Shari R. Waldstein. (2016) Relations of blood pressure and head injury to regional cerebral blood flow. Journal of the Neurological Sciences 365, pages 9-14.
Crossref
Carola I. F. Janssen, Diane Jansen, Martina P. C. Mutsaers, Pieter J. W. C. Dederen, Bram Geenen, Monique T. Mulder & Amanda J. Kiliaan. (2016) The Effect of a High-Fat Diet on Brain Plasticity, Inflammation and Cognition in Female ApoE4-Knockin and ApoE-Knockout Mice. PLOS ONE 11:5, pages e0155307.
Crossref
Daniela Carnevale, Marialuisa Perrotta, Giuseppe Lembo & Bruno Trimarco. (2015) Pathophysiological Links Among Hypertension and Alzheimer’s Disease. High Blood Pressure & Cardiovascular Prevention 23:1, pages 3-7.
Crossref
Joaquín Lasierra-Cirujeda, María José Aza Pascual-Salcedo & María Mercedes Aza Pascual-Salcedo. (2016) Sulodexide and Alzheimer’s Disease: A Preliminary Prospective Study. World Journal of Cardiovascular Diseases 06:02, pages 54-71.
Crossref
Fei Ma, Tianfeng Wu, Jiangang Zhao, Lu Ji, Aili Song, Meilin Zhang & Guowei Huang. (2016) Prevalence of Mild Cognitive Impairment and Its Subtypes among Chinese Older Adults: Role of Vascular Risk Factors. Dementia and Geriatric Cognitive Disorders 41:5-6, pages 261-272.
Crossref
Paulo W. Pires & Anne M. Dorrance. 2016. Hypertension and the Brain as an End-Organ Target. Hypertension and the Brain as an End-Organ Target 99 134 .
Dima Obari, Sefika Ozturk Ozcelik, Hélène Girouard & Edith Hamel. 2016. Hypertension and the Brain as an End-Organ Target. Hypertension and the Brain as an End-Organ Target 71 97 .
Ashley A. Martin. 2016. Metabolic Syndrome. Metabolic Syndrome 709 722 .
Crystal M. Ghantous, Zeina Azrak, Farah Abdel Rahman, Hana A. Itani & Asad Zeidan. 2016. Injury Models of the Central Nervous System. Injury Models of the Central Nervous System 625 643 .
M. Florencia Iulita & Hélène Girouard. 2017. Hypertension: from basic research to clinical practice. Hypertension: from basic research to clinical practice 447 473 .
Lin Lu, Lan Guo, Esha Gauba, Jing Tian, Lu Wang, Neha Tandon, Malini Shankar, Simon J. Beck, Yifeng Du & Heng Du. (2015) Transient Cerebral Ischemia Promotes Brain Mitochondrial Dysfunction and Exacerbates Cognitive Impairments in Young 5xFAD Mice. PLOS ONE 10:12, pages e0144068.
Crossref
Pedro Cisternas, Carolina B. Lindsay, Paulina Salazar, Carmen Silva-Alvarez, Rocio M. Retamales, Felipe G. Serrano, Carlos P. Vio & Nibaldo C. Inestrosa. (2015) The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1852:12, pages 2630-2644.
Crossref
Shu-Chen Kuo, Shih-Wei Lai, Hung-Chang Hung, Chih-Hsin Muo, Shih-Chang Hung, Ling-Ling Liu, Chia-Wei Chang, Yueh-Juen Hwu, Shieh-Liang Chen & Fung-Chung Sung. (2015) Association between comorbidities and dementia in diabetes mellitus patients: population-based retrospective cohort study. Journal of Diabetes and its Complications 29:8, pages 1071-1076.
Crossref
Jessica C. Foster-Dingley, Jeroen van der Grond, Justine E.F. Moonen, Anne A. van den Berg-Huijsmans, Wouter de Ruijter, Mark A. van Buchem, Anton J.M. de Craen & Roos C. van der Mast. (2015) Lower Blood Pressure Is Associated With Smaller Subcortical Brain Volumes in Older Persons. American Journal of Hypertension 28:9, pages 1127-1133.
Crossref
Janessa O. Carvalho, Doug Tommet, Paul K. Crane, Michael L. Thomas, Amy Claxton, Christian Habeck, Jennifer J. Manly & Heather R. Romero. (2015) Deconstructing Racial Differences: The Effects of Quality of Education and Cerebrovascular Risk Factors. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences 70:4, pages 545-556.
Crossref
Christopher E. Gonzalez, Jennifer Pacheco, Lori L. Beason-Held & Susan M. Resnick. (2015) Longitudinal changes in cortical thinning associated with hypertension. Journal of Hypertension 33:6, pages 1242-1248.
Crossref
Shuai Bai, Muhua Mao, Libing Tian, Yanzhen Yu, Jiujiang Zeng, Kai Ouyang, Lidong Yu, Linling Li, Danbi Wang, Xianqing Deng, Churong Wei & Yougen Luo. (2015) Calcium sensing receptor mediated the excessive generation of β-amyloid peptide induced by hypoxia in vivo and in vitro. Biochemical and Biophysical Research Communications 459:4, pages 568-573.
Crossref
Tomoko Kurata, Violeta Lukic, Miki Kozuki, Daisuke Wada, Kazunori Miyazaki, Nobutoshi Morimoto, Yasuyuki Ohta, Kentaro Deguchi, Toru Yamashita, Nozomi Hishikawa, Kosuke Matsuzono, Yoshio Ikeda, Tatsushi Kamiya & Koji Abe. (2014) Long-term Effect of Telmisartan on Alzheimer’s Amyloid Genesis in SHR-SR After tMCAO. Translational Stroke Research 6:2, pages 107-115.
Crossref
Fan Fan, Aron M. Geurts, Sydney R. Murphy, Mallikarjuna R. Pabbidi, Howard J. Jacob & Richard J. Roman. (2015) Impaired myogenic response and autoregulation of cerebral blood flow is rescued in CYP4A1 transgenic Dahl salt-sensitive rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 308:5, pages R379-R390.
Crossref
Jong Hun Kim, Seok Min Go, Sang Won Seo, Suk Hui Kim, Juhee Chin, So Young Moon, Hyunsun Lim, Hae Kwan Cheong, Sun Ah Choi, Jun Hong Lee & Duk L. Na. (2015) Survival in Subcortical Vascular Dementia: Predictors and Comparison to Probable Alzheimer's Disease in a Tertiary Memory Clinic Population. Dementia and Geriatric Cognitive Disorders 40:3-4, pages 210-221.
Crossref
Mahmood Rasool, Arif Malik, Abdul Manan, Misbah Sultana, Mahmood Husain Qazi & Peter Natesan Pushparaj. 2015. Proteostasis and Chaperone Surveillance. Proteostasis and Chaperone Surveillance 89 103 .
Ashley A. Martin. 2014. Metabolic Syndrome. Metabolic Syndrome 1 16 .
Chun-Yan WangZhan-You WangJing-Wei XieJian-Hui CaiTao WangYe XuXu WangLi An. (2014) CD36 Upregulation Mediated by Intranasal LV-NRF2 Treatment Mitigates Hypoxia-Induced Progression of Alzheimer's-Like Pathogenesis. Antioxidants & Redox Signaling 21:16, pages 2208-2230.
Crossref
Lesly A Pearce, Leslie A McClure, David C Anderson, Claudia Jacova, Mukul Sharma, Robert G Hart & Oscar R Benavente. (2014) Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial. The Lancet Neurology 13:12, pages 1177-1185.
Crossref
Yi-Fang Chuang, John C.S. Breitner, Yen-Ling Chiu, Ara Khachaturian, Kathleen Hayden, Chris Corcoran, JoAnn Tschanz, Maria Norton, Ron Munger, Kathleen Welsh-Bohmer & Peter P. Zandi. (2014) Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study. Neurobiology of Aging 35:11, pages 2429-2435.
Crossref
Tomoko Kurata, Violeta Lukic, Miki Kozuki, Daisuke Wada, Kazunori Miyazaki, Nobutoshi Morimoto, Yasuyuki Ohta, Kentaro Deguchi, Yoshio Ikeda, Tatsushi Kamiya & Koji Abe. (2014) Telmisartan Reduces Progressive Accumulation of Cellular Amyloid Beta and Phosphorylated Tau with Inflammatory Responses in Aged Spontaneously Hypertensive Stroke Resistant Rat. Journal of Stroke and Cerebrovascular Diseases 23:10, pages 2580-2590.
Crossref
Walter T Ambrosius, Kaycee M Sink, Capri G Foy, Dan R Berlowitz, Alfred K Cheung, William C Cushman, Lawrence J Fine, David C GoffJrJr, Karen C Johnson, Anthony A Killeen, Cora E Lewis, Suzanne Oparil, David M Reboussin, Michael V Rocco, Joni K Snyder, Jeff D Williamson, Jackson T WrightJrJr & Paul K Whelton. (2014) The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT). Clinical Trials 11:5, pages 532-546.
Crossref
Juvenal A. Ríos, Pedro Cisternas, Marco Arrese, Salesa Barja & Nibaldo C. Inestrosa. (2014) Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum. Progress in Neurobiology 121, pages 125-146.
Crossref
Toru Yamashita, Yun Zhai, Tomoko Kurata, Nozomi Hishikawa, Nobutoshi Morimoto, Yasuyuki Ohta, Kentaro Deguchi & Koji Abe. (2014) Strong Improvement of Apolipoprotein E/Low-Density Lipoprotein Receptor Signals by Telmisartan in Poststroke Spontaneously Hypertensive Stroke Resistant. Journal of Stroke and Cerebrovascular Diseases 23:9, pages 2240-2249.
Crossref
David A. Drachman. (2014) The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease. Alzheimer's & Dementia 10:3, pages 372-380.
Crossref
Wei-Che Chiu, Wen-Chao Ho, Meng-Hung Lin, Hsiu-Hao Lee, Yu-Chi Yeh, Jung-Der Wang & Pau-Chung Chen. (2014) Angiotension receptor blockers reduce the risk of dementia. Journal of Hypertension 32:4, pages 938-947.
Crossref
Zheng Wang, Xiao‐Jie Zhang, Ting Li, Jia Li, Yu Tang & Weidong Le. (2013) Valproic Acid Reduces Neuritic Plaque Formation and Improves Learning Deficits in APP Swe / PS 1 A246E Transgenic Mice via Preventing the Prenatal Hypoxia‐Induced Down‐Regulation of Neprilysin . CNS Neuroscience & Therapeutics 20:3, pages 209-217.
Crossref
Yuri I. Arshavsky. (2014) Alzheimer Disease and Cellular Mechanisms of Memory Storage. Journal of Neuropathology & Experimental Neurology 73:3, pages 192-205.
Crossref
Carola I.F. Janssen & Amanda J. Kiliaan. (2014) Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: The influence of LCPUFA on neural development, aging, and neurodegeneration. Progress in Lipid Research 53, pages 1-17.
Crossref
Giuseppe FaracoCostantino Iadecola. (2013) Hypertension. Hypertension 62:5, pages 810-817.
Crossref
Melinda C. Power, Eric J. Tchetgen Tchetgen, David Sparrow, Joel Schwartz & Marc G. Weisskopf. (2013) Blood Pressure and Cognition. Epidemiology 24:6, pages 886-893.
Crossref
Maximilian Wiesmann, Amanda J Kiliaan & Jurgen AHR Claassen. (2013) Vascular Aspects of Cognitive Impairment and Dementia. Journal of Cerebral Blood Flow & Metabolism 33:11, pages 1696-1706.
Crossref
Marta Dobarro, Gorka Gerenu & María J Ramírez. (2013) Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice. International Journal of Neuropsychopharmacology 16:10, pages 2245-2257.
Crossref
Jing-Zhang Wang, Shu-Rui Li, Ya-Li Li, Yong-Ze Zhang, Ting Zhang, Chao-Xian Zhao, Chun-Xia Yao & Lin-Fang Du. (2013) Could Pin1 help us conquer essential hypertension at an earlier stage? A promising early-diagnostic biomarker and its therapeutic implications for the disease. Medical Hypotheses 81:5, pages 931-935.
Crossref
Anna Csiszar, Zsuzsanna TucsekPeter TothDanuta SosnowskaTripti GautamAkos Koller, Ferenc DeakWilliam E. Sonntag & Zoltan Ungvari. (2013) Synergistic effects of hypertension and aging on cognitive function and hippocampal expression of genes involved in β-amyloid generation and Alzheimer's disease. American Journal of Physiology-Heart and Circulatory Physiology 305:8, pages H1120-H1130.
Crossref
Diane Jansen, Valerio Zerbi, Ilse A. C. Arnoldussen, Maximilian Wiesmann, Anne Rijpma, Xiaotian T. Fang, Pieter J. Dederen, Martina P. C. Mutsaers, Laus M. Broersen, Dieter Lütjohann, Malgorzata Miller, Leo A. B. Joosten, Arend Heerschap & Amanda J. Kiliaan. (2013) Effects of Specific Multi-Nutrient Enriched Diets on Cerebral Metabolism, Cognition and Neuropathology in AβPPswe-PS1dE9 Mice. PLoS ONE 8:9, pages e75393.
Crossref
Stefan J. Teipel. (2013) Risk and resilience: A new perspective on Alzheimer's disease. Geriatric Mental Health Care 1:3, pages 47-55.
Crossref
Lianbo Gao, Shen Tian, Honghua Gao & Yanyuan Xu. (2013) Hypoxia Increases Aβ-Induced Tau Phosphorylation by Calpain and Promotes Behavioral Consequences in AD Transgenic Mice. Journal of Molecular Neuroscience 51:1, pages 138-147.
Crossref
Diane Jansen, Valerio Zerbi, Carola I. F. Janssen, Daan van Rooij, Bastian Zinnhardt, Pieter J. Dederen, Alan J. Wright, Laus M. Broersen, Dieter Lütjohann, Arend Heerschap & Amanda J. Kiliaan. (2013) Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice. Brain Structure and Function.
Crossref
Chun-Yan Wang, Jing-Wei Xie, Tao Wang, Ye Xu, Jian-Hui Cai, Xu Wang, Bao-Lu Zhao, Li An & Zhan-You Wang. (2013) Hypoxia-Triggered m-Calpain Activation Evokes Endoplasmic Reticulum Stress and Neuropathogenesis in a Transgenic Mouse Model of Alzheimer's Disease. CNS Neuroscience & Therapeutics, pages n/a-n/a.
Crossref
Ihab Hajjar & Kathleen Rodgers. (2013) Do angiotensin receptor blockers prevent Alzheimer's disease?. Current Opinion in Cardiology 28:4, pages 417-425.
Crossref
Mathew J. Sharman, Seyyed H. Moussavi Nik, Mengqi M. Chen, Daniel Ong, Linda Wijaya, Simon M. Laws, Kevin Taddei, Morgan Newman, Michael Lardelli, Ralph N. Martins & Giuseppe Verdile. (2013) The Guinea Pig as a Model for Sporadic Alzheimer’s Disease (AD): The Impact of Cholesterol Intake on Expression of AD-Related Genes. PLoS ONE 8:6, pages e66235.
Crossref
Paulo W. Pires, Carla M. Dams Ramos, Nusrat Matin & Anne M. Dorrance. (2013) The effects of hypertension on the cerebral circulation. American Journal of Physiology-Heart and Circulatory Physiology 304:12, pages H1598-H1614.
Crossref
María del Carmen Puertas, José Manuel Martínez-Martos, Manuela Cobo, Pedro Lorite, Rosa María Sandalio, Teresa Palomeque, María Isabel Torres, María Pilar Carrera-González, María Dolores Mayas & María Jesús Ramírez-Expósito. (2013) Plasma renin–angiotensin system-regulating aminopeptidase activities are modified in early stage Alzheimer's disease and show gender differences but are not related to apolipoprotein E genotype. Experimental Gerontology 48:6, pages 557-564.
Crossref
E.V. Kugaevskaya. (2013) Angiotensin converting enzyme and Alzheimer's disease. Biomeditsinskaya Khimiya 59:1, pages 5-24.
Crossref
Carrington R. Wendell, Leslie I. Katzel & Shari R. Waldstein. 2013. Handbook of Systems and Complexity in Health. Handbook of Systems and Complexity in Health 379 396 .
Jerzy Leszek, Marta Sochocka & Kazimierz Gąsiorowski. (2012) Vascular factors and epigenetic modifications in the pathogenesis of Alzheimer's disease. Journal of the Neurological Sciences 323:1-2, pages 25-32.
Crossref
Giuliano Pinna, Claudio Pascale, Micaela La Regina & Francesco Orlandini. (2012) Hypertension in the elderly. Italian Journal of Medicine 6:4, pages 285-294.
Crossref
Cheuk Ying Tang, Jagat Narula & Joseph I. Friedman. (2012) Novel Imaging Strategies for Assessment of Cerebrovascular Involvement. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 79:6, pages 674-682.
Crossref
I. B. Zueva, A. S. Ulitina, D. N. Ghorab, M. V. Moskalenko & M. V. Dubina. (2012) Apo E gene polymorphism in patients with metabolic syndrome and cognitive disorders. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 18:5, pages 421-428.
Crossref
Daniela CarnevaleGiada MascioIvana D'AndreaValentina FardellaRobert D. BellIgor BranchiFabio PallanteBerislav ZlokovicShirley ShiDu YanGiuseppe Lembo. (2012) Hypertension Induces Brain β-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature. Hypertension 60:1, pages 188-197.
Crossref
E. V. Kugaevskaya. (2012) Angiotensin converting enzyme and Alzheimer’s disease. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 6:1, pages 11-22.
Crossref
K. E. Innes, T. K. Selfe, C. J. Brown, K. M. Rose & A. Thompson-Heisterman. (2012) The Effects of Meditation on Perceived Stress and Related Indices of Psychological Status and Sympathetic Activation in Persons with Alzheimer's Disease and Their Caregivers: A Pilot Study. Evidence-Based Complementary and Alternative Medicine 2012, pages 1-9.
Crossref
Perminder S. Sachdev, Darren M. Lipnicki, John Crawford, Simone Reppermund, Nicole A. Kochan, Julian N. Trollor, Brian Draper, Melissa J. Slavin, Kristan Kang, Ora Lux, Karen A. Mather & Henry Brodaty. (2011) Risk Profiles of Subtypes of Mild Cognitive Impairment: The S ydney Memory and Ageing Study . Journal of the American Geriatrics Society 60:1, pages 24-33.
Crossref
Daniela Carnevale, Giada Mascio, Maria Antonietta Ajmone-Cat, Ivana D'Andrea, Giuseppe Cifelli, Michele Madonna, Germana Cocozza, Alessandro Frati, Pierluigi Carullo, Lorenzo Carnevale, Enrico Alleva, Igor Branchi, Giuseppe Lembo & Luisa Minghetti. (2012) Role of neuroinflammation in hypertension-induced brain amyloid pathology. Neurobiology of Aging 33:1, pages 205.e19-205.e29.
Crossref
A. Mitnitski, N. Fallah, M. R. H. Rockwood & K. Rockwood. (2011) Transitions in cognitive status in relation to frailty in older adults: A Comparison of three frailty measures. The journal of nutrition, health & aging 15:10, pages 863-867.
Crossref
L. Reig-Puig, I. Antón-Rodrigo & P. Sánchez-Ferrín. (2011) Relación entre hipertensión arterial y la demencia. Hipertensión y Riesgo Vascular 28:5-6, pages 182-195.
Crossref
Daniela Carnevale & Giuseppe Lembo. (2011) ‘Alzheimer-like’ pathology in a murine model of arterial hypertension. Biochemical Society Transactions 39:4, pages 939-944.
Crossref
Wilbert S. Aronow, Jerome L. Fleg, Carl J. Pepine, Nancy T. Artinian, George Bakris, Alan S. Brown, Keith C. Ferdinand, Mary Ann Forciea, William H. Frishman, Cheryl Jaigobin, John B. Kostis, Giuseppi Mancia, Suzanne Oparil, Eduardo Ortiz, Efrain Reisin, Michael W. Rich, Douglas D. Schocken, Michael A. Weber, Deborah J. Wesley, Robert A. Harrington, Eric R. Bates, Deepak L. Bhatt, Charles R. Bridges, Mark J. Eisenberg, Victor A. Ferrari, John D. Fisher, Timothy J. Gardner, Federico Gentile, Michael F. Gilson, Mark A. Hlatky, Alice K. Jacobs, Sanjay Kaul, David J. Moliterno, Debabrata Mukherjee, Robert S. Rosenson, James H. Stein, Howard H. Weitz & Deborah J. Wesley. (2011) ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly. Journal of the American Society of Hypertension 5:4, pages 259-352.
Crossref
Philine Schneider, Katharina Buerger, Stefan Teipel, Olga Uspenskaya, Oliver Hartmann, Oskar Hansson, Lennart Minthon, Dan Rujescu, Hans-Juergen Moeller, Henrik Zetterberg, Kaj Blennow, Andrea Ernst, Andreas Bergmann & Harald Hampel. (2011) Antihypertensive Therapy Is Associated with Reduced Rate of Conversion to Alzheimer's Disease in Midregional Proatrial Natriuretic Peptide Stratified Subjects with Mild Cognitive Impairment. Biological Psychiatry 70:2, pages 145-151.
Crossref
Jennifer Palmer & Seth Love. (2011) Endothelin receptor antagonists: Potential in Alzheimer's disease. Pharmacological Research 63:6, pages 525-531.
Crossref
Wilbert S. AronowJerome L. FlegCarl J. PepineNancy T. ArtinianGeorge Bakris, Alan S. BrownKeith C. FerdinandMary Ann ForcieaWilliam H. FrishmanCheryl JaigobinJohn B. Kostis, Giuseppi ManciaSuzanne Oparil, Eduardo OrtizEfrain ReisinMichael W. RichDouglas D. SchockenMichael A. WeberDeborah J. Wesley. (2011) ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly. Circulation 123:21, pages 2434-2506.
Crossref
Wilbert S. Aronow, Jerome L. Fleg, Carl J. Pepine, Nancy T. Artinian, George Bakris, Alan S. Brown, Keith C. Ferdinand, Mary Ann Forciea, William H. Frishman, Cheryl Jaigobin, John B. Kostis, Giuseppi Mancia, Suzanne Oparil, Eduardo Ortiz, Efrain Reisin, Michael W. Rich, Douglas D. Schocken, Michael A. Weber & Deborah J. Wesley. (2011) ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly. Journal of the American College of Cardiology 57:20, pages 2037-2114.
Crossref
D. Strubel. (2011) Maladie d’Alzheimer et pathologie cardiovasculaireAlzheimer’s disease and cardio-vascular pathology. Les cahiers de l'année gérontologique 3:1, pages 5-12.
Crossref
Donglin Zhu, Jingping Shi, Yingdong Zhang, Bianrong Wang, Wei Liu, Zhicong Chen & Qiang Tong. (2011) Central Angiotensin II Stimulation Promotes β Amyloid Production in Sprague Dawley Rats. PLoS ONE 6:1, pages e16037.
Crossref
Adrià Arboix. (2011) Arterial hypertension, cerebrovascular diseases and dementia. World Journal of Hypertension 1:1, pages 7.
Crossref
Giulio Maria Pasinetti, Jun Wang, Shanee Porter & Lap Ho. (2011) Caloric Intake, Dietary Lifestyles, Macronutrient Composition, and Alzheimer’ Disease Dementia. International Journal of Alzheimer's Disease 2011, pages 1-12.
Crossref
Vikas Dhikav & Kuljeet Anand. (2011) Potential Predictors of Hippocampal Atrophy in Alzheimerʼs Disease. Drugs & Aging 28:1, pages 1-11.
Crossref
H.C. Fivecoat & G.M. Pasinetti. 2011. Lifetime Nutritional Influences on Cognition, Behaviour and Psychiatric Illness. Lifetime Nutritional Influences on Cognition, Behaviour and Psychiatric Illness 439 463 .
Elizabeth Schwartz, Bridget Wicinski, James Schmeidler, Vahram Haroutunian & Patrick Hof. (2010) Cardiovascular risk factors affect hippocampal microvasculature in early AD. Translational Neuroscience 1:4, pages 292-299.
Crossref
Daniela Carnevale & Giuseppe Lembo. (2010) Hypertension and Cerebrovascular Dysfunction. High Blood Pressure & Cardiovascular Prevention 17:4, pages 191-200.
Crossref
Robin AltmanJohn C. Rutledge. (2010) The vascular contribution to Alzheimer's disease. Clinical Science 119:10, pages 407-421.
Crossref
Suvi Rovio, Gabriela Spulber, Lasse J. Nieminen, Eini Niskanen, Bengt Winblad, Jaakko Tuomilehto, Aulikki Nissinen, Hilkka Soininen & Miia Kivipelto. (2010) The effect of midlife physical activity on structural brain changes in the elderly. Neurobiology of Aging 31:11, pages 1927-1936.
Crossref
S.K. DasA.K. MisraB.K. RayA. HazraM.K. GhosalA. ChaudhuriT. RoyT.K. BanerjeeD.K. Raut. (2010) Epidemiology of Parkinson disease in the city of Kolkata, India. Neurology 75:15, pages 1362-1369.
Crossref
Valérie Leduc, Stéphanie Jasmin-Bélanger & Judes Poirier. (2010) APOE and cholesterol homeostasis in Alzheimer's disease. Trends in Molecular Medicine 16:10, pages 469-477.
Crossref
MA Phillips. (2010) Omega-3 fatty acids, cognitive impairment and Alzheimer's disease. Reviews in Clinical Gerontology 20:3, pages 219-238.
Crossref
David Zade, Alexa Beiser, Regina McGlinchey, Rhoda Au, Sudha Seshadri, Carole Palumbo, Philip A. Wolf, Charles DeCarli & William Milberg. (2010) Interactive Effects of Apolipoprotein E Type 4 Genotype and Cerebrovascular Risk on Neuropsychological Performance and Structural Brain Changes. Journal of Stroke and Cerebrovascular Diseases 19:4, pages 261-268.
Crossref
Adrià Arboix, Marta Grau-Olivares & Jerzy Krupinski. 2011. Therapeutic Angiogenesis for Vascular Diseases. Therapeutic Angiogenesis for Vascular Diseases 313 338 .
Shari R. Waldstein, Carrington Rice Wendell, Megan M. Hosey, Stephen L. Seliger & Leslie I. Katzel. 2010. Handbook of Medical Neuropsychology. Handbook of Medical Neuropsychology 69 99 .
Dara L. Dickstein, Jessica Walsh, Hannah Brautigam, Steven D. StocktonJrJr, Samuel Gandy & Patrick R. Hof. (2010) Role of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 77:1, pages 82-102.
Crossref
Patrick G. Kehoe, Scott Miners & Seth Love. (2009) Angiotensins in Alzheimer's disease – friend or foe?. Trends in Neurosciences 32:12, pages 619-628.
Crossref
Angela CliffordAmina Yesufu UdechukuLouisa EdwardsStephan BandelowEef Hogervorst. (2009) Maintaining cognitive health in elderly women. Aging Health 5:5, pages 655-670.
Crossref
Carolyn PierceJanice Pecen & Kenneth J. McLeod. (2009) Influence of Seated Rocking on Blood Pressure in the Elderly: A Pilot Clinical Study. Biological Research For Nursing 11:2, pages 144-151.
Crossref
Chris Peers, Mark L. Dallas, Hannah E. Boycott, Jason L. Scragg, Hugh A. Pearson & John P. Boyle. (2009) Hypoxia and Neurodegeneration. Annals of the New York Academy of Sciences 1177:1, pages 169-177.
Crossref
C. Díaz-Ruiz, J. Wang, H. Ksiezak-Reding, L. Ho, X. Qian, N. Humala, S. Thomas, P. Martínez-Martín & G. M. Pasinetti. (2009) Role of Hypertension in Aggravating A Neuropathology of AD Type and Tau-Mediated Motor Impairment . Cardiovascular Psychiatry and Neurology 2009, pages 1-9.
Crossref
Cheryl Gies & Mira Lessick. (2009) Alzheimer Disease in Women: A Clinical and Genetics Perspective. Nursing for Women's Health 13:4, pages 312-324.
Crossref
Vikas Dhikav, Myank Verma & Kuljeet Anand. (2009) Is hypertension a predictor of hippocampal atrophy in Alzheimer's disease?. International Psychogeriatrics 21:04, pages 795.
Crossref
Liang Li, Xiaojie Zhang, Dehua Yang, Guangrui Luo, Shen Chen & Weidong Le. (2009) Hypoxia increases Aβ generation by altering β- and γ-cleavage of APP. Neurobiology of Aging 30:7, pages 1091-1098.
Crossref
Xu Zhu, Wei Zhou, Yongyao Cui, Liang Zhu, Juan Li, Zheng Xia, Biyun Shao, Hao Wang & Hongzhuan Chen. (2009) Muscarinic activation attenuates abnormal processing of β-amyloid precursor protein induced by cobalt chloride-mimetic hypoxia in retinal ganglion cells. Biochemical and Biophysical Research Communications 384:1, pages 110-113.
Crossref
M.D.M. HaagA. HofmanP. J. KoudstaalM. M.B. BretelerB. H.C. Stricker. (2009) Duration of antihypertensive drug use and risk of dementia. Neurology 72:20, pages 1727-1734.
Crossref
C. Iadecola, L. Park & C. Capone. (2008) Threats to the Mind: Aging, Amyloid, and Hypertension. Stroke 40:3, Supplement 1, pages S40-S44.
Crossref
C.R. Hooijmans, C.E.E.M. Van der Zee, P.J. Dederen, K.M. Brouwer, Y.D. Reijmer, T. van Groen, L.M. Broersen, D. Lütjohann, A. Heerschap & A.J. Kiliaan. (2009) DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiology of Disease 33:3, pages 482-498.
Crossref
B. KuczynskiW. JagustH. C. ChuiB. Reed. (2009) An inverse association of cardiovascular risk and frontal lobe glucose metabolism. Neurology 72:8, pages 738-743.
Crossref
Maria Teresa Gentile, Roberta Poulet, Alba Di Pardo, Giuseppe Cifelli, Angelo Maffei, Carmine Vecchione, Francesca Passarelli, Alessandro Landolfi, Pierluigi Carullo & Giuseppe Lembo. (2009) β-Amyloid deposition in brain is enhanced in mouse models of arterial hypertension. Neurobiology of Aging 30:2, pages 222-228.
Crossref
Ghania Ait-ghezala, Laila Abdullah, Claude-Henry Volmar, Daniel Paris, Cheryl A. Luis, Amita Quadros, Benoit Mouzon, Myles A. Mullan, Andrew P. Keegan, Julia Parrish, Fiona C. Crawford, Venkatarajan S. Mathura & Michael J. Mullan. (2008) Diagnostic utility of APOE, soluble CD40, CD40L, and Aβ1–40 levels in plasma in Alzheimer’s disease. Cytokine 44:2, pages 283-287.
Crossref
T Psaltopoulou, A Kyrozis, P Stathopoulos, D Trichopoulos, D Vassilopoulos & A Trichopoulou. (2008) Diet, physical activity and cognitive impairment among elders: the EPIC–Greece cohort (European Prospective Investigation into Cancer and Nutrition). Public Health Nutrition 11:10, pages 1054-1062.
Crossref
Ingmar Skoog. (2008) Antihypertensive treatment and dementia prevention. The Lancet Neurology 7:8, pages 664-665.
Crossref
Valerie C. CrooksJames LubbenDiana B. PetittiDeborah LittleVicki Chiu. (2008) Social Network, Cognitive Function, and Dementia Incidence Among Elderly Women. American Journal of Public Health 98:7, pages 1221-1227.
Crossref
Myron F. Weiner, Roger N. Rosenberg, Kyle B. Womack, Doris A. Svetlik, Carey Fuller, Julie Fields & Linda S. Hynan. (2008) Atherosclerosis Risk Factors in American Indians With Alzheimer Disease. Alzheimer Disease & Associated Disorders 22:3, pages 245-248.
Crossref
Eszter Herczenik & Martijn F. B. G. Gebbink. (2008) Molecular and cellular aspects of protein misfolding and disease. The FASEB Journal 22:7, pages 2115-2133.
Crossref
Costantino Iadecola & Robin L. Davisson. (2008) Hypertension and Cerebrovascular Dysfunction. Cell Metabolism 7:6, pages 476-484.
Crossref
Carlijn R. Hooijmans & Amanda J. Kiliaan. (2008) Fatty acids, lipid metabolism and Alzheimer pathology. European Journal of Pharmacology 585:1, pages 176-196.
Crossref
Ivy O. Poon. (2012) Effects of Antihypertensive Drug Treatment on the Risk of Dementia and Cognitive Impairment. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28:3, pages 366-375.
Crossref
Thomas Olabode Obisesan, Odunayo Abiodun Obisesan, Sayyida Martins, Laila Alamgir, Vernon Bond, Celia Maxwell & Richard Frank Gillum. (2008) High Blood Pressure, Hypertension, and High Pulse Pressure Are Associated with Poorer Cognitive Function in Persons Aged 60 and Older: The Third National Health and Nutrition Examination Survey. Journal of the American Geriatrics Society 56:3, pages 501-509.
Crossref
Kurt D Christensen, J Scott Roberts, Charmaine D M Royal, Grace-Ann Fasaye, Thomas Obisesan, L Adrienne Cupples, Peter J Whitehouse, Melissa Barber Butson, Erin Linnenbringer, Norman R Relkin, Lindsay Farrer, Robert Cook-Deegan & Robert C Green. (2008) Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience. Genetics in Medicine 10:3, pages 207-214.
Crossref
Quan Zhefeng, Hirokazu Bokura, Kenichi Iijima, Hiroaki Oguro & Shuhei Yamaguchi. (2008) The influences of silent cerebral infarction and hypertension on brain atrophy in normal adults. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 45:2, pages 175-181.
Crossref
Pedro Gil, José Luis Dobato Ayuso, José Manuel Marey, Manuel Antón & Carlos Guzmán Quilo. (2008) Variability in the Diagnosis and Management of Patients with Alzheimerʼs Disease and Cerebrovascular Disease. Clinical Drug Investigation 28:7, pages 429-437.
Crossref
Sven Kurbel. (2008) Is sympathetic activation by stressful memories linked to the occurrence of hypertension and metabolic syndrome?. Bioscience Hypotheses 1:4, pages 179-184.
Crossref
Gjumrakch Aliev, Yi Li, Hector H. Palacios, Mark E. Obrenovich, Valentin Bragin, Ilya Bragin, Elena Shevtsova, Sergey G. Klochkov, Elena A. Kosenko, Yury G. Kaminsky, Sergey O. Bachurin & Ramon Cacabelos. 2014. Systems Biology of Free Radicals and Antioxidants. Systems Biology of Free Radicals and Antioxidants 2127 2145 .
Jean-Pierre Clément. (2007) Facteurs de risque et facteurs protecteurs des démences. Morphologie 91:295, pages 207-220.
Crossref
Pavel Katsel, Celeste Li & Vahram Haroutunian. (2007) Gene Expression Alterations in the Sphingolipid Metabolism Pathways during Progression of Dementia and Alzheimer’s Disease: A Shift Toward Ceramide Accumulation at the Earliest Recognizable Stages of Alzheimer’s Disease?. Neurochemical Research 32:4-5, pages 845-856.
Crossref
Regina A. Shih, Howard Hu, Marc G. Weisskopf & Brian S. Schwartz. (2007) Cumulative Lead Dose and Cognitive Function in Adults: A Review of Studies That Measured Both Blood Lead and Bone Lead. Environmental Health Perspectives 115:3, pages 483-492.
Crossref

Displaying 200 of 202 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.